SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Shares of Palantir are experiencing volatility, with community chatter focusing on a report highlighting security concerns with a U.S. Army communications system. Despite the dip, some investors view this as a buying opportunity, citing the company's response that the issues were addressed and emphasizing Palantir's broader role in AI and government contracts, while others point to valuation concerns.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending due to a mix of factors, including discussions around AI investments, competition in the AR/VR space, and overall market sentiment. Some traders express concerns about capital expenditure and potential overvaluation, while others see a buying opportunity amidst the recent dip, citing strong fundamentals and future growth potential. Community discussions also include potential partnerships, technical analysis, and speculation around upcoming earnings and the overall market's direction.

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.

Black Titan Corp.

Black Titan Corp. ($BTTC) is trending due to the closing of its merger, sparking significant after-hours volatility and a short squeeze fueled by community excitement. Traders are actively discussing potential further upside, with some eyeing specific price levels and comparing it to other high-momentum stocks. The community is focused on short positions and the possibility of a continued squeeze.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid discussions around market volatility and potential manipulation, with some investors viewing the dip as a buying opportunity. Community members are debating the company's long-term prospects, particularly in light of new competition and generic alternatives, while others express optimism about its expansion into hormonal health and potential for a short squeeze. The stock's high short interest and upcoming earnings are also key talking points.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around the crypto, emphasizing its connection to cannabis culture and its potential for growth. Conversations highlight the coin's unique positioning and related website.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as investors eagerly anticipate upcoming catalysts, potentially including news from airshows and progress on airworthiness certification. Community members are actively discussing potential short squeezes and comparing ACHR's potential to competitor JOBY. There is also chatter around possible partnerships, with some speculating about a collaboration with Tesla.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing pressure as a trending topic amidst calls for boycotts related to concerns over content, particularly regarding children's programming. Community discussions involve debates about cancel culture, the company's creative direction, and its broader societal impact. Some investors view the dip as a buying opportunity, while others anticipate further decline.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as the community discusses its recent price movement, increased volume, and potential catalysts, including a possible buyout. Community members are analyzing chart patterns and speculating on a buyout, with some pointing to the company's new license structure and partnership with Recordati as potential drivers. Others discuss the possibility of a sector-related surge and the potential for future profitability.

The project is a groundbreaking memecoin powered by advanced AI that interacts with the community across platforms like X (formerly Twitter). The AI generates unique content, including text, images, videos, music, and animations, all based on current trends. As it learns from user interactions, the AI becomes more responsive, providing engaging and dynamic experiences. Holders are rewarded with exclusive content, voting rights, and governance opportunities, creating an interactive ecosystem that evolves with the community.

Shadow AI

Shadow AI ($SHADOAI) is trending as the community discusses its potential breakout and future prospects within the Solana ecosystem. Speculation is focused on its potential trajectory, with many expressing bullish sentiment. The token's connection to both Solana ($SOL) and Bitcoin ($BTC) is also a key point of discussion.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

Alto Neuroscience is trending due to FDA Fast Track designation for ALTO-101, a potential treatment for cognitive impairment associated with schizophrenia, a condition with no currently approved options. Community members are discussing the potential for a significant price increase and buyout speculation given the news and the company's pipeline. Bullish sentiment is fueled by institutional ownership and upcoming clinical study readouts, with some traders anticipating a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell?

Tempus AI posts 89.6% Q2 revenue growth, raises 2025 sales outlook again, and sees positive adjusted EBITDA ahead. What is the investment outlook?

Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024

Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 PR Newswire BURLINGTON, Mass., Feb. 5, 2025...

Azenta Announces the Election of Dipal Doshi to its Board of Directors

Azenta Announces the Election of Dipal Doshi to its Board of Directors Azenta Announces the Election of Dipal Doshi to its Board of Directors PR Newswire BURLINGTON, Mass., Jan. 30, 2025 BURLINGTON...

Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast

Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast PR Newswire BURLINGTON, Mass., Jan. 27...

UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence

UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System...

Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 PR Newswire...

Azenta to Participate in Stephens Annual Investment Conference

Azenta to Participate in Stephens Annual Investment Conference Azenta to Participate in Stephens Annual Investment Conference PR Newswire BURLINGTON, Mass., Nov. 14, 2024 BURLINGTON, Mass., Nov. 14...

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO Azenta Reports Fourth Quarter and Full Year Fiscal...

A Look Ahead: Azenta's Earnings Forecast

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value Azenta Announces the Addition of Three New Independent Directors Effective...

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Azenta Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.19	--	--	N/A
Q3 '25	$0.14	$0.19	39.45%	BEAT
Q2 '25	$0.07	$0.05	-28.57%	MISSED
Q1 '25	$0.06	$0.08	40.00%	BEAT
Q4 '24	$0.10	$0.18	75.59%	BEAT

AZTA
Azenta Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest AZTA News

AZTA Azenta Inc